Home ➤ Life Science ➤ Pharmaceuticals ➤ Anti-Malarial Drugs Market
Anti-Malarial Drugs Market
Published date: Nov 2024 • Formats:
Request Sample Schedule a Call

Anti-Malarial Drugs Market By Drug Class (Antifolate Compounds, Artemisinin Compounds, Aryl Aminoalcohol Compounds, and Others), By Malaria Type (Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, and Plasmodium Ovale), By Distribution Channel (Hospital Pharmacy, E-Commerce, Retail Pharmacy, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Nov 2024
  • Report ID: 132974
  • Number of Pages: 251
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Anti-malarial Drugs Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Anti-malarial Drugs Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Anti-malarial Drugs Market Analysis and Forecast, By Segment, 2019-2033
      • 3.1. Key Findings
      • 3.2. Global Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 3.3. Global Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
        • 3.3.1. Antifolate Compounds
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Artemisinin Compounds
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Aryl Aminoalcohol Compounds
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Others
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
      • 3.4. Global Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Malaria Type, 2019-2033
      • 3.5. Global Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
        • 3.5.1. Plasmodium Falciparum
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Plasmodium Malariae
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Plasmodium Vivax
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Plasmodium Ovale
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
      • 3.6. Global Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 3.7. Global Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
        • 3.7.1. Hospital Pharmacy
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. E-Commerce
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Retail Pharmacy
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Others
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
    • 4. Global Anti-malarial Drugs Market Analysis and Forecast, By Region, 2019-2033
      • 4.1. Key Findings
      • 4.2. Global Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Anti-malarial Drugs Market Attractiveness Analysis, By Region
    • 5. North America Anti-malarial Drugs Market Analysis and Forecast, 2019-2033
      • 5.1. Key Findings
      • 5.2. North America Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 5.3. North America Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • 5.4. North America Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Malaria Type, 2019-2033
      • 5.5. North America Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • 5.6. North America Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 5.7. North America Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • 5.8. North America Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 5.9. North America Anti-malarial Drugs Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Anti-malarial Drugs Market Analysis and Forecast, 2019-2033
      • 6.1. Key Findings
      • 6.2. Europe Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 6.3. Europe Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • 6.4. Europe Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Malaria Type, 2019-2033
      • 6.5. Europe Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • 6.6. Europe Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 6.7. Europe Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • 6.8. Europe Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 6.9. Europe Anti-malarial Drugs Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Anti-malarial Drugs Market Analysis and Forecast, 2019-2033
      • 7.1. Key Findings
      • 7.2. Asia Pacific Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 7.3. Asia Pacific Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • 7.4. Asia Pacific Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Malaria Type, 2019-2033
      • 7.5. Asia Pacific Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • 7.6. Asia Pacific Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 7.7. Asia Pacific Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • 7.8. Asia Pacific Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 7.9. Asia Pacific Anti-malarial Drugs Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Anti-malarial Drugs Market Analysis and Forecast, 2019-2033
      • 8.1. Key Findings
      • 8.2. Latin America Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 8.3. Latin America Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • 8.4. Latin America Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Malaria Type, 2019-2033
      • 8.5. Latin America Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • 8.6. Latin America Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 8.7. Latin America Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • 8.8. Latin America Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 8.9. Latin America Anti-malarial Drugs Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Anti-malarial Drugs Market Analysis and Forecast, 2019-2033
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 9.3. Middle East & Africa Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • 9.4. Middle East & Africa Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Malaria Type, 2019-2033
      • 9.5. Middle East & Africa Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • 9.6. Middle East & Africa Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 9.7. Middle East & Africa Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • 9.8. Middle East & Africa Anti-malarial Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 9.9. Middle East & Africa Anti-malarial Drugs Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Zydus Healthcare Ltd.
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Viatris Inc.
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Sun Pharmaceutical Industries Ltd.
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Sanofi SA
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Novartis AG
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Lupin
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. GSK Plc.
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Cipla Ltd
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 2. Global Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 3. Global Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 4. Global Anti-malarial Drugs Market Value (US$ Mn), By Region, 2019-2033
      • Table 5. North America Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 6. North America Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 7. North America Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 8. North America Anti-malarial Drugs Market Value (US$ Mn), By Country, 2019-2033
      • Table 9. The US Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 10. The US Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 11. The US Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 12. Canada Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 13. Canada Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 14. Canada Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 15. Europe Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 16. Europe Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 17. Europe Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 18. Europe Anti-malarial Drugs Market Value (US$ Mn), By Country, 2019-2033
      • Table 19. Germany Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 20. Germany Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 21. Germany Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 22. The UK Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 23. The UK Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 24. The UK Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 25. France Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 26. France Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 27. France Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 28. Spain Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 29. Spain Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 30. Spain Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 31. Italy Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 32. Italy Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 33. Italy Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 34. Russia Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 35. Russia Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 36. Russia Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 37. Netherland Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 38. Netherland Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 39. Netherland Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 40. Rest of Europe Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 41. Rest of Europe Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 42. Rest of Europe Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 43. Asia Pacific Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 44. Asia Pacific Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 45. Asia Pacific Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 46. Asia Pacific Anti-malarial Drugs Market Value (US$ Mn), By Country, 2019-2033
      • Table 47. China Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 48. China Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 49. China Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 50. India Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 51. India Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 52. India Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 53. Japan Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 54. Japan Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 55. Japan Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 56. South Korea Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 57. South Korea Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 58. South Korea Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 59. Australia Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 60. Australia Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 61. Australia Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 62. New Zealand Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 63. New Zealand Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 64. New Zealand Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 65. Singapore Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 66. Singapore Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 67. Singapore Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 68. Thailand Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 69. Thailand Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 70. Thailand Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 71. Vietnam Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 72. Vietnam Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 73. Vietnam Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 74. Rest of Asia Pacific Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 75. Rest of Asia Pacific Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 76. Rest of Asia Pacific Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 77. Latin America Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 78. Latin America Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 79. Latin America Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 80. Latin America Anti-malarial Drugs Market Value (US$ Mn), By Country, 2019-2033
      • Table 81. Brazil Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 82. Brazil Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 83. Brazil Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 84. Mexico Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 85. Mexico Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 86. Mexico Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 87. Rest of Latin America Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 88. Rest of Latin America Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 89. Rest of Latin America Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 90. Middle East & Africa Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 91. Middle East & Africa Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 92. Middle East & Africa Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 93. Middle East & Africa Anti-malarial Drugs Market Value (US$ Mn), By Country, 2019-2033
      • Table 94. South Africa Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 95. South Africa Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 96. South Africa Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 97. Saudi Arabia Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 98. Saudi Arabia Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 99. Saudi Arabia Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 100. UAE Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 101. UAE Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 102. UAE Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 103. Rest of Middle East & Africa Anti-malarial Drugs Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 104. Rest of Middle East & Africa Anti-malarial Drugs Market Value (US$ Mn), By Malaria Type, 2019-2033
      • Table 105. Rest of Middle East & Africa Anti-malarial Drugs Market Value (US$ Mn), By Distribution Channel, 2019-2033
    • List of Figures
      • Figure 1. Global Anti-malarial Drugs Market Snapshot: Market Value (US$ Mn), 2019-2033
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Anti-malarial Drugs Market
      • Figure 5. Global Anti-malarial Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 6. Global Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • Figure 7. Global Anti-malarial Drugs Market Analysis, By Malaria Type, 2019, 2023 and 2033
      • Figure 8. Global Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • Figure 9. Global Anti-malarial Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 10. Global Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • Figure 11. Global Anti-malarial Drugs Market Analysis, By Region, 2019, 2023 and 2033
      • Figure 12. Global Anti-malarial Drugs Market Attractiveness Analysis, By Region
      • Figure 13. North America Anti-malarial Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 14. North America Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • Figure 15. North America Anti-malarial Drugs Market (US$ Mn), by Antifolate Compounds, 2019-2033
      • Figure 16. North America Anti-malarial Drugs Market (US$ Mn), by Artemisinin Compounds, 2019-2033
      • Figure 17. North America Anti-malarial Drugs Market (US$ Mn), by Aryl Aminoalcohol Compounds, 2019-2033
      • Figure 18. North America Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 19. North America Anti-malarial Drugs Market Analysis, By Malaria Type, 2019, 2023 and 2033
      • Figure 20. North America Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • Figure 21. North America Anti-malarial Drugs Market (US$ Mn), by Plasmodium Falciparum, 2019-2033
      • Figure 22. North America Anti-malarial Drugs Market (US$ Mn), by Plasmodium Malariae, 2019-2033
      • Figure 23. North America Anti-malarial Drugs Market (US$ Mn), by Plasmodium Vivax, 2019-2033
      • Figure 24. North America Anti-malarial Drugs Market (US$ Mn), by Plasmodium Ovale, 2019-2033
      • Figure 25. North America Anti-malarial Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 26. North America Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • Figure 27. North America Anti-malarial Drugs Market (US$ Mn), by Hospital Pharmacy, 2019-2033
      • Figure 28. North America Anti-malarial Drugs Market (US$ Mn), by E-Commerce, 2019-2033
      • Figure 29. North America Anti-malarial Drugs Market (US$ Mn), by Retail Pharmacy, 2019-2033
      • Figure 30. North America Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 31. North America Anti-malarial Drugs Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 32. North America Anti-malarial Drugs Market Attractiveness Analysis, By Country
      • Figure 33. Europe Anti-malarial Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 34. Europe Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • Figure 35. Europe Anti-malarial Drugs Market (US$ Mn), by Antifolate Compounds, 2019-2033
      • Figure 36. Europe Anti-malarial Drugs Market (US$ Mn), by Artemisinin Compounds, 2019-2033
      • Figure 37. Europe Anti-malarial Drugs Market (US$ Mn), by Aryl Aminoalcohol Compounds, 2019-2033
      • Figure 38. Europe Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 39. Europe Anti-malarial Drugs Market Analysis, By Malaria Type, 2019, 2023 and 2033
      • Figure 40. Europe Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • Figure 41. Europe Anti-malarial Drugs Market (US$ Mn), by Plasmodium Falciparum, 2019-2033
      • Figure 42. Europe Anti-malarial Drugs Market (US$ Mn), by Plasmodium Malariae, 2019-2033
      • Figure 43. Europe Anti-malarial Drugs Market (US$ Mn), by Plasmodium Vivax, 2019-2033
      • Figure 44. Europe Anti-malarial Drugs Market (US$ Mn), by Plasmodium Ovale, 2019-2033
      • Figure 45. Europe Anti-malarial Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 46. Europe Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • Figure 47. Europe Anti-malarial Drugs Market (US$ Mn), by Hospital Pharmacy, 2019-2033
      • Figure 48. Europe Anti-malarial Drugs Market (US$ Mn), by E-Commerce, 2019-2033
      • Figure 49. Europe Anti-malarial Drugs Market (US$ Mn), by Retail Pharmacy, 2019-2033
      • Figure 50. Europe Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 51. Europe Anti-malarial Drugs Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 52. Europe Anti-malarial Drugs Market Attractiveness Analysis, By Country
      • Figure 53. Asia Pacific Anti-malarial Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 54. Asia Pacific Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • Figure 55. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Antifolate Compounds, 2019-2033
      • Figure 56. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Artemisinin Compounds, 2019-2033
      • Figure 57. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Aryl Aminoalcohol Compounds, 2019-2033
      • Figure 58. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 59. Asia Pacific Anti-malarial Drugs Market Analysis, By Malaria Type, 2019, 2023 and 2033
      • Figure 60. Asia Pacific Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • Figure 61. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Plasmodium Falciparum, 2019-2033
      • Figure 62. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Plasmodium Malariae, 2019-2033
      • Figure 63. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Plasmodium Vivax, 2019-2033
      • Figure 64. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Plasmodium Ovale, 2019-2033
      • Figure 65. Asia Pacific Anti-malarial Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 66. Asia Pacific Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • Figure 67. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Hospital Pharmacy, 2019-2033
      • Figure 68. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by E-Commerce, 2019-2033
      • Figure 69. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Retail Pharmacy, 2019-2033
      • Figure 70. Asia Pacific Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 71. Asia Pacific Anti-malarial Drugs Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 72. Asia Pacific Anti-malarial Drugs Market Attractiveness Analysis, By Country
      • Figure 73. Latin America Anti-malarial Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 74. Latin America Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • Figure 75. Latin America Anti-malarial Drugs Market (US$ Mn), by Antifolate Compounds, 2019-2033
      • Figure 76. Latin America Anti-malarial Drugs Market (US$ Mn), by Artemisinin Compounds, 2019-2033
      • Figure 77. Latin America Anti-malarial Drugs Market (US$ Mn), by Aryl Aminoalcohol Compounds, 2019-2033
      • Figure 78. Latin America Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 79. Latin America Anti-malarial Drugs Market Analysis, By Malaria Type, 2019, 2023 and 2033
      • Figure 80. Latin America Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • Figure 81. Latin America Anti-malarial Drugs Market (US$ Mn), by Plasmodium Falciparum, 2019-2033
      • Figure 82. Latin America Anti-malarial Drugs Market (US$ Mn), by Plasmodium Malariae, 2019-2033
      • Figure 83. Latin America Anti-malarial Drugs Market (US$ Mn), by Plasmodium Vivax, 2019-2033
      • Figure 84. Latin America Anti-malarial Drugs Market (US$ Mn), by Plasmodium Ovale, 2019-2033
      • Figure 85. Latin America Anti-malarial Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 86. Latin America Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • Figure 87. Latin America Anti-malarial Drugs Market (US$ Mn), by Hospital Pharmacy, 2019-2033
      • Figure 88. Latin America Anti-malarial Drugs Market (US$ Mn), by E-Commerce, 2019-2033
      • Figure 89. Latin America Anti-malarial Drugs Market (US$ Mn), by Retail Pharmacy, 2019-2033
      • Figure 90. Latin America Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 91. Latin America Anti-malarial Drugs Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 92. Latin America Anti-malarial Drugs Market Attractiveness Analysis, By Country
      • Figure 93. Middle East & Africa Anti-malarial Drugs Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 94. Middle East & Africa Anti-malarial Drugs Market Attractiveness Analysis, By Drug Class
      • Figure 95. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Antifolate Compounds, 2019-2033
      • Figure 96. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Artemisinin Compounds, 2019-2033
      • Figure 97. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Aryl Aminoalcohol Compounds, 2019-2033
      • Figure 98. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 99. Middle East & Africa Anti-malarial Drugs Market Analysis, By Malaria Type, 2019, 2023 and 2033
      • Figure 100. Middle East & Africa Anti-malarial Drugs Market Attractiveness Analysis, By Malaria Type
      • Figure 101. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Plasmodium Falciparum, 2019-2033
      • Figure 102. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Plasmodium Malariae, 2019-2033
      • Figure 103. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Plasmodium Vivax, 2019-2033
      • Figure 104. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Plasmodium Ovale, 2019-2033
      • Figure 105. Middle East & Africa Anti-malarial Drugs Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 106. Middle East & Africa Anti-malarial Drugs Market Attractiveness Analysis, By Distribution Channel
      • Figure 107. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Hospital Pharmacy, 2019-2033
      • Figure 108. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by E-Commerce, 2019-2033
      • Figure 109. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Retail Pharmacy, 2019-2033
      • Figure 110. Middle East & Africa Anti-malarial Drugs Market (US$ Mn), by Others, 2019-2033
      • Figure 111. Middle East & Africa Anti-malarial Drugs Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 112. Middle East & Africa Anti-malarial Drugs Market Attractiveness Analysis, By Country

Related Reports

Our Clients

  • Our Clients
Anti-Malarial Drugs Market
  • 132974
  • Nov 2024
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options